Home » Newsletters » BioWorld Asia

BioWorld Asia

Aug. 8, 2001

View Archived Issues

Pharmacia Spins Off Metabolic Disease Business Into Biovitrum

Ionix Secures #8M In First Round For Ion Channel Work

OSI Acquiring Discovery Arm From British Biotech For $12.4M

Genfit Concludes Two More Deals With Pharma Companies

Compugen, Novartis Collaborate To Accelerate Target Identification

Tibotec-Virco Consolidates Operations In Belgium, U.S.

CellFactors Plans Funding After Getting Bone-Related U.S. Patent

Ichor Changes Name, Continues Focus On Retroviral Diseases

Other News To Note

Pharmexa Plans Spin-Off For Additional Vaccine Applications

Pharming Contemplates Avenues Available To Continue Business

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026